Anti-EGFR therapy combined with neuromedin B receptor blockade induces the death of DAOY medulloblastoma cells.

作者: Mariane Jaeger , Carolina Nör , Caroline Brunetto de Farias , Ana Lucia Abujamra , Gilberto Schwartsmann

DOI: 10.1007/S00381-013-2290-6

关键词: MedicineCancer researchCetuximabBrain tumorInternal medicineEpidermal growth factor receptorGrowth factor receptorNeuromedin B receptorMedulloblastomaEndocrinologyProgrammed cell deathGrowth factor receptor inhibitor

摘要: Purpose Medulloblastoma is the most common malignant childhood brain tumor for which development of new molecularly targeted therapies needed. Novel therapeutic targets under investigation include growth factor receptors. Here, we show that combined inhibition epidermal receptor (EGFR) and neuromedin B (NMBR, BB1) results in increased cell death human medulloblastoma lines.

参考文章(36)
Tetsuya Mitsudomi, Yasushi Yatabe, Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer FEBS Journal. ,vol. 277, pp. 301- 308 ,(2010) , 10.1111/J.1742-4658.2009.07448.X
J. E. TAYLOR, P. A. EDEN, Identification of Gastrin-Releasing Peptide and Neuromedin B Receptors on Established Tumors and Tumor Cell Lines. Annals of the New York Academy of Sciences. ,vol. 739, pp. 350- 352 ,(1994) , 10.1111/J.1749-6632.1994.TB19845.X
R T Jensen, D H Coy, T W Moody, F Zia, J Staley, Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines. Journal of Pharmacology and Experimental Therapeutics. ,vol. 263, pp. 311- 317 ,(1992)
Carolina Nör, Caroline Brunetto de Farias, Ana Lucia Abujamra, Gilberto Schwartsmann, Algemir Lunardi Brunetto, Rafael Roesler, The histone deacetylase inhibitor sodium butyrate in combination with brain-derived neurotrophic factor reduces the viability of DAOY human medulloblastoma cells Childs Nervous System. ,vol. 27, pp. 897- 901 ,(2011) , 10.1007/S00381-011-1439-4
Olivier Bouché, Giordano Domenico Beretta, Pilar García Alfonso, Michael Geissler, The role of anti-epidermal growth factor receptor monoclonal antibody monotherapy in the treatment of metastatic colorectal cancer. Cancer Treatment Reviews. ,vol. 36, ,(2010) , 10.1016/S0305-7372(10)00036-8
Anna Laura Schmidt, Caroline Brunetto de Farias, Ana Lucia Abujamra, Flávio Kapczinski, Gilberto Schwartsmann, Algemir Lunardi Brunetto, Rafael Roesler, BDNF and PDE4, but not the GRPR, regulate viability of human medulloblastoma cells. Journal of Molecular Neuroscience. ,vol. 40, pp. 303- 310 ,(2010) , 10.1007/S12031-009-9221-8
Terry W Moody, Robert T Jensen, Luis Garcia, Julius Leyton, Nonpeptide neuromedin B receptor antagonists inhibit the proliferation of C6 cells European Journal of Pharmacology. ,vol. 409, pp. 133- 142 ,(2000) , 10.1016/S0014-2999(00)00828-1
Carolina Nör, Felipe A. Sassi, Caroline Brunetto de Farias, Gilberto Schwartsmann, Ana Lucia Abujamra, Guido Lenz, Algemir Lunardi Brunetto, Rafael Roesler, The Histone Deacetylase Inhibitor Sodium Butyrate Promotes Cell Death and Differentiation and Reduces Neurosphere Formation in Human Medulloblastoma Cells Molecular Neurobiology. ,vol. 48, pp. 533- 543 ,(2013) , 10.1007/S12035-013-8441-7
Stephanie E Combs, Steffen Heeger, Renate Haselmann, Lutz Edler, Jürgen Debus, Daniela Schulz-Ertner, Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT)--phase I/II trial: study protocol. BMC Cancer. ,vol. 6, pp. 133- 133 ,(2006) , 10.1186/1471-2407-6-133
Jeffrey D. McDonald, George J. Dohrmann, Molecular biology of brain tumors. Neurosurgery. ,vol. 23, pp. 537- 544 ,(1988) , 10.1227/00006123-198811000-00001